Ascendis Pharma Oncology Division A/s

This early-stage study tested a new drug designed to stimulate the immune system to fight cancer. The drug was injected directly into tumors, either by itself or combined with an existing immunotherapy (pembrolizumab), in people with advanced solid tumors. The main goals were to …